1. State of oncological care in Russia in 2019. Eds.: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI im. P.A. Gertsena - filial FGBU “NMITS radiologii” Minzdrava Rossii, 2020. 236 p. (In Russ.).
2. Huggins C., Hodges C.V. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;19:293-7.
3. Crawford E.D. Hormonal therapy in prostate cancer: historical approaches. Rev Urol 2004;6(Suppl 7):S3-11.
4. Mottet N., Bellmunt J., Briers E. et al. Guidelines on prostate cancer. 2016. Available at: https://uroweb.org/guideline/prostate-cancer/.
5. Tunn U.W., Wiedey K. Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe. Prostate Cancer Prostatic Dis 2009;12(1):83-7. DOI: 10.1038/pcan.2008.52.